In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

People with MS who carry the APOE4 gene variant show greater signs of nerve damage and cognitive decline than those who don't ...

People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

Guest writer Karen Matingou promised her teenage son she would face living with MS with strength, discipline, and a warrior ...

Guest writer Jamie Hughes taps into her expertise in literary criticism to provide a new lens to view living with MS.

Guest writer Caitlin Epstein was in the middle of world travels when her MS symptoms worsened, leading to a diagnosis.

Guest writer Shayna Goerdt shares the ups and downs of her journey with MS. Among the highs is advocating for the community, ...

Immunic Therapeutics was granted a patent in Europe that protects all dosing regimens of its MS therapy vidofludimus calcium ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

Guest writer Josh Bell regrets not focusing on the mental and emotional side of living with MS more quickly after he was diagnosed.

A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability ...